[EN] QUATERNARY SALT CCR2 ANTAGONISTS<br/>[FR] ANTAGONISTES DE CCR2 A BASE DE SELS QUATERNAIRES
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006012135A1
公开(公告)日:2006-02-02
Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
Formula (I)的四价盐化合物或其药学上可接受的形式,其为CCR2拮抗剂,可用于预防、治疗或改善CCR2介导的炎症综合征、疾病或症状。